• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South Korea Pharmacovigilance Market

    ID: MRFR/Pharma/49096-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South Korea Pharmacovigilance Market Research Report By Service Type (Adverse Event Reporting, Risk Assessment, Data Mining, Pharmacovigilance Consulting), By Deployment Mode (Cloud-Based, On-Premise), By Source (Spontaneous Reporting, Literature Reports, Scheduled Reporting) and By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South Korea Pharmacovigilance Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    South Korea Pharmacovigilance Market Summary

    The South Korea Pharmacovigilance market is projected to grow from 158 USD Million in 2024 to 315 USD Million by 2035.

    Key Market Trends & Highlights

    South Korea Pharmacovigilance Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 6.47% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 315 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 158 USD Million, reflecting the current demand for pharmacovigilance services.
    • Growing adoption of advanced data analytics due to increasing regulatory requirements is a major market driver.

    Market Size & Forecast

    2024 Market Size 158 (USD Million)
    2035 Market Size 315 (USD Million)
    CAGR (2025-2035) 6.47%

    Major Players

    Pfizer, Boehringer Ingelheim, Samsung Biologics, Janssen Pharmaceuticals, Celltrion, Merck, Hanmi Pharmaceutical, AstraZeneca, Roche, GSK, SK Biopharmaceuticals, LG Chem, Amgen, Novartis, Sanofi

    South Korea Pharmacovigilance Market Trends

    Significant changes are being observed in the South Korea Pharmacovigilance Market as a result of the growing focus on medication safety and regulatory compliance. Pharmaceutical companies now have a greater obligation to maintain thorough safety profiles for their goods following the implementation of strict laws and guidelines by the South Korean government to ensure the monitoring of adverse medication responses. The emphasis on compliance is reinforced by technological developments, especially the use of artificial intelligence and data analytics, which enable more effective monitoring and reporting procedures.

    Furthermore, the business now has a plethora of growth prospects due to the increased demand for improved patient safety. Pharmaceutical companies are being compelled to improve their pharmacovigilance systems and make investments in cutting-edge solutions as patients and healthcare professionals see the value of pharmacovigilance growing. Additionally, cooperation has been encouraged between pharmaceutical players and regulatory bodies, resulting in a more open atmosphere where shared data can improve safety initiatives. Current developments underscore the significance of empirical data in pharmacovigilance procedures.

    The Ministry of Food and Drug Safety in South Korea promotes the incorporation of real-world data to enhance the evaluation of drug efficacy and safety across a range of demographics.Furthermore, pharmacovigilance is changing due to the growing number of patients reporting adverse events, which highlights the necessity of more patient-centric methods of safety monitoring. A dedication to enhancing public health is demonstrated by South Korea's leadership in pharmaceutical innovation, which propels the country's pharmacovigilance market's expansion as the environment changes.

    South Korea Pharmacovigilance Market Drivers

    Market Segment Insights

    Get more detailed insights about South Korea Pharmacovigilance Market Research Report-Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The South Korea Pharmacovigilance Market has seen significant growth in recent years due to various factors such as increasing awareness of drug safety, the rising burden of chronic diseases, and strict government regulations regarding drug monitoring and reporting. This market is characterized by an ongoing evolution in regulatory frameworks, technological advancements, and the emphasis on patient safety, leading to a highly competitive landscape. Companies operating in this space must navigate complex regulatory requirements while incorporating innovative technologies to enhance their pharmacovigilance capabilities.

    Competitive dynamics are influenced by both global pharmaceutical giants and local firms, focusing on developing robust safety monitoring systems and improving patient engagement. This has resulted in collaborations, partnerships, and mergers as firms strive to strengthen their market positions and enhance service delivery.Pfizer has established a strong footprint in the South Korea Pharmacovigilance Market, leveraging its vast global experience and resources. The company's commitment to drug safety is reflected in its comprehensive monitoring systems, which allow for effective identification and assessment of adverse drug reactions.

    Pfizer's strengths lie in its robust regulatory compliance and proactive pharmacovigilance practices, which have earned the trust of regulators and healthcare professionals in South Korea. By utilizing advanced data analytics and real-time reporting tools, Pfizer is able to manage drug safety information efficiently, ensuring prompt action and enhanced patient safety.

    Additionally, the company's collaboration with local healthcare providers and regulatory bodies further strengthens its presence in the market, fostering a collaborative approach to pharmacovigilance that enhances public health outcomes.Boehringer Ingelheim has made significant inroads in the South Korea Pharmacovigilance Market through its localized strategies and focus on therapeutic areas where it holds expertise. The company is recognized for its commitment to innovation and quality in pharmaceuticals, especially in areas such as respiratory and cardiometabolic diseases. Boehringer Ingelheim’s strength in pharmacovigilance lies in its tailored services and products designed to monitor drug safety across various indications.

    The firm has also engaged in strategic partnerships and collaborations, enhancing its capability to adapt to the dynamic regulatory environment in South Korea. Key products support its pharmacovigilance efforts by integrating safety monitoring into the drug development cycle. Mergers and acquisitions have bolstered its market position, allowing Boehringer Ingelheim to expand its portfolio and consolidate its operational efficiencies, thereby reinforcing its competitive edge in providing comprehensive and reliable pharmacovigilance services in the region.

    Key Companies in the South Korea Pharmacovigilance Market market include

    Industry Developments

    The South Korea Pharmacovigilance Market has recently seen significant developments, with major companies like Pfizer, Boehringer Ingelheim, and Samsung Biologics increasing their focus on enhancing drug safety systems. Notably, in September 2023, Merck announced a partnership with Korean health authorities to strengthen safety monitoring for its recently launched pharmaceuticals. Growth in the South Korean pharmaceutical sector has propelled organizations to expand their Pharmacovigilance capabilities, coupled with ongoing investments in technology to ensure compliance with regulatory requirements.

    Additionally, in June 2022, AstraZeneca announced a strategic acquisition of a local biotech firm, further consolidating their market position and enhancing their drug safety programs. The market is projected to continue developing due to increased demand for effective monitoring of drug safety and adverse reactions, fueled by advances in digital health technologies. Since 2021, South Korea's Ministry of Food and Drug Safety has emphasized the importance of robust Pharmacovigilance practices, ensuring that companies like GSK, LG Chem, and Amgen remain compliant with evolving regulations. Together, these factors contribute to a dynamic environment within the South Korea Pharmacovigilance Market.

    Market Segmentation

    Outlook

    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 149.0(USD Million)
    MARKET SIZE 2024 158.0(USD Million)
    MARKET SIZE 2035 315.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.473% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Pfizer, Boehringer Ingelheim, Samsung Biologics, Janssen Pharmaceuticals, Celltrion, Merck, Hanmi Pharmaceutical, AstraZeneca, Roche, GSK, SK Biopharmaceuticals, LG Chem, Amgen, Novartis, Sanofi
    SEGMENTS COVERED Service Type, Deployment Mode, Source, End User
    KEY MARKET OPPORTUNITIES Growing demand for real-time monitoring, Increase in regulatory compliance requirements, Expansion of biopharmaceutical sector, Advancements in AI technologies, Rising focus on patient safety initiatives
    KEY MARKET DYNAMICS Regulatory compliance requirements, Increasing adverse drug reactions, Advancement in technology, Growing emphasis on patient safety, Expanding pharmaceutical industry
    COUNTRIES COVERED South Korea

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the South Korea Pharmacovigilance Market by 2024?

    The South Korea Pharmacovigilance Market is expected to be valued at 158.0 USD Million by the year 2024.

    What is the projected market size for the South Korea Pharmacovigilance Market by 2035?

    By 2035, the South Korea Pharmacovigilance Market is projected to reach a value of 315.0 USD Million.

    What is the expected CAGR for the South Korea Pharmacovigilance Market from 2025 to 2035?

    The expected CAGR for the South Korea Pharmacovigilance Market from 2025 to 2035 is 6.473%.

    Which service type will dominate the South Korea Pharmacovigilance Market in 2024?

    Adverse Event Reporting is expected to dominate the South Korea Pharmacovigilance Market in 2024, valued at 45.0 USD Million.

    What is the expected market value of Risk Assessment by 2035 in the South Korea Pharmacovigilance Market?

    The market value for Risk Assessment in the South Korea Pharmacovigilance Market is expected to be 60.0 USD Million by 2035.

    Who are the major players in the South Korea Pharmacovigilance Market?

    Major players in the South Korea Pharmacovigilance Market include Pfizer, Boehringer Ingelheim, Samsung Biologics, and Merck.

    What is the expected market value for Data Mining services by 2035?

    Data Mining services in the South Korea Pharmacovigilance Market are expected to be valued at 80.0 USD Million by 2035.

    How much is the Pharmacovigilance Consulting service expected to be valued in 2024?

    The Pharmacovigilance Consulting service is expected to be valued at 43.0 USD Million in 2024.

    What are the growth drivers for the South Korea Pharmacovigilance Market?

    The growth drivers for the South Korea Pharmacovigilance Market include increasing awareness and regulatory requirements.

    What will be the expected market value of Adverse Event Reporting by 2035?

    The expected market value for Adverse Event Reporting in the South Korea Pharmacovigilance Market by 2035 will be 90.0 USD Million.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. South
    59. Korea Pharmacovigilance Market, BY Service Type (USD Million)
    60. Adverse
    61. Event Reporting
    62. Risk Assessment
    63. Data
    64. Mining
    65. Pharmacovigilance Consulting
    66. South
    67. Korea Pharmacovigilance Market, BY Deployment Mode (USD Million)
    68. Cloud-Based
    69. On-Premise
    70. South
    71. Korea Pharmacovigilance Market, BY Source (USD Million)
    72. Spontaneous
    73. Reporting
    74. Literature Reports
    75. Scheduled
    76. Reporting
    77. South Korea Pharmacovigilance
    78. Market, BY End User (USD Million)
    79. Pharmaceutical
    80. Companies
    81. Biotechnology Companies
    82. Contract
    83. Research Organizations
    84. Competitive Landscape
    85. Overview
    86. Competitive
    87. Analysis
    88. Market share Analysis
    89. Major
    90. Growth Strategy in the Pharmacovigilance Market
    91. Competitive
    92. Benchmarking
    93. Leading Players in Terms of Number of Developments
    94. in the Pharmacovigilance Market
    95. Key developments and
    96. growth strategies
    97. New Product Launch/Service Deployment
    98. Merger
    99. & Acquisitions
    100. Joint Ventures
    101. Major
    102. Players Financial Matrix
    103. Sales and Operating Income
    104. Major
    105. Players R&D Expenditure. 2023
    106. Company
    107. Profiles
    108. Pfizer
    109. Financial
    110. Overview
    111. Products Offered
    112. Key
    113. Developments
    114. SWOT Analysis
    115. Key
    116. Strategies
    117. Boehringer Ingelheim
    118. Financial
    119. Overview
    120. Products Offered
    121. Key
    122. Developments
    123. SWOT Analysis
    124. Key
    125. Strategies
    126. Samsung Biologics
    127. Financial
    128. Overview
    129. Products Offered
    130. Key
    131. Developments
    132. SWOT Analysis
    133. Key
    134. Strategies
    135. Janssen Pharmaceuticals
    136. Financial
    137. Overview
    138. Products Offered
    139. Key
    140. Developments
    141. SWOT Analysis
    142. Key
    143. Strategies
    144. Celltrion
    145. Financial
    146. Overview
    147. Products Offered
    148. Key
    149. Developments
    150. SWOT Analysis
    151. Key
    152. Strategies
    153. Merck
    154. Financial
    155. Overview
    156. Products Offered
    157. Key
    158. Developments
    159. SWOT Analysis
    160. Key
    161. Strategies
    162. Hanmi Pharmaceutical
    163. Financial
    164. Overview
    165. Products Offered
    166. Key
    167. Developments
    168. SWOT Analysis
    169. Key
    170. Strategies
    171. AstraZeneca
    172. Financial
    173. Overview
    174. Products Offered
    175. Key
    176. Developments
    177. SWOT Analysis
    178. Key
    179. Strategies
    180. Roche
    181. Financial
    182. Overview
    183. Products Offered
    184. Key
    185. Developments
    186. SWOT Analysis
    187. Key
    188. Strategies
    189. GSK
    190. Financial
    191. Overview
    192. Products Offered
    193. Key
    194. Developments
    195. SWOT Analysis
    196. Key
    197. Strategies
    198. SK Biopharmaceuticals
    199. Financial
    200. Overview
    201. Products Offered
    202. Key
    203. Developments
    204. SWOT Analysis
    205. Key
    206. Strategies
    207. LG Chem
    208. Financial
    209. Overview
    210. Products Offered
    211. Key
    212. Developments
    213. SWOT Analysis
    214. Key
    215. Strategies
    216. Amgen
    217. Financial
    218. Overview
    219. Products Offered
    220. Key
    221. Developments
    222. SWOT Analysis
    223. Key
    224. Strategies
    225. Novartis
    226. Financial
    227. Overview
    228. Products Offered
    229. Key
    230. Developments
    231. SWOT Analysis
    232. Key
    233. Strategies
    234. Sanofi
    235. Financial
    236. Overview
    237. Products Offered
    238. Key
    239. Developments
    240. SWOT Analysis
    241. Key
    242. Strategies
    243. References
    244. Related
    245. Reports
    246. LIST
    247. OF ASSUMPTIONS
    248. South Korea Pharmacovigilance Market SIZE
    249. ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD Billions)
    250. South
    251. Korea Pharmacovigilance Market SIZE ESTIMATES & FORECAST, BY DEPLOYMENT MODE,
    252. 2035 (USD Billions)
    253. South Korea Pharmacovigilance
    254. Market SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD Billions)
    255. South
    256. Korea Pharmacovigilance Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035
    257. (USD Billions)
    258. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    259. ACQUISITION/PARTNERSHIP
    260. LIST
    261. Of figures
    262. MARKET SYNOPSIS
    263. SOUTH
    264. KOREA PHARMACOVIGILANCE MARKET ANALYSIS BY SERVICE TYPE
    265. SOUTH
    266. KOREA PHARMACOVIGILANCE MARKET ANALYSIS BY DEPLOYMENT MODE
    267. SOUTH
    268. KOREA PHARMACOVIGILANCE MARKET ANALYSIS BY SOURCE
    269. SOUTH
    270. KOREA PHARMACOVIGILANCE MARKET ANALYSIS BY END USER
    271. KEY
    272. BUYING CRITERIA OF PHARMACOVIGILANCE MARKET
    273. RESEARCH
    274. PROCESS OF MRFR
    275. DRO ANALYSIS OF PHARMACOVIGILANCE MARKET
    276. DRIVERS
    277. IMPACT ANALYSIS: PHARMACOVIGILANCE MARKET
    278. RESTRAINTS
    279. IMPACT ANALYSIS: PHARMACOVIGILANCE MARKET
    280. SUPPLY / VALUE
    281. CHAIN: PHARMACOVIGILANCE MARKET
    282. PHARMACOVIGILANCE MARKET,
    283. BY SERVICE TYPE, 2025 (% SHARE)
    284. PHARMACOVIGILANCE MARKET,
    285. BY SERVICE TYPE, 2019 TO 2035 (USD Billions)
    286. PHARMACOVIGILANCE
    287. MARKET, BY DEPLOYMENT MODE, 2025 (% SHARE)
    288. PHARMACOVIGILANCE
    289. MARKET, BY DEPLOYMENT MODE, 2019 TO 2035 (USD Billions)
    290. PHARMACOVIGILANCE
    291. MARKET, BY SOURCE, 2025 (% SHARE)
    292. PHARMACOVIGILANCE MARKET,
    293. BY SOURCE, 2019 TO 2035 (USD Billions)
    294. PHARMACOVIGILANCE
    295. MARKET, BY END USER, 2025 (% SHARE)
    296. PHARMACOVIGILANCE
    297. MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    298. BENCHMARKING
    299. OF MAJOR COMPETITORS

    South Korea Pharmacovigilance Market Segmentation

    • Pharmacovigilance Market By Service Type (USD Million, 2019-2035)

      • Adverse Event Reporting
      • Risk Assessment
      • Data Mining
      • Pharmacovigilance Consulting

     

    • Pharmacovigilance Market By Deployment Mode (USD Million, 2019-2035)

      • Cloud-Based
      • On-Premise

     

    • Pharmacovigilance Market By Source (USD Million, 2019-2035)

      • Spontaneous Reporting
      • Literature Reports
      • Scheduled Reporting

     

    • Pharmacovigilance Market By End User (USD Million, 2019-2035)

      • Pharmaceutical Companies
      • Biotechnology Companies
      • Contract Research Organizations
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials